Pietrasanta, C.; Ronchi, A.; Vener, C.; Poggi, C.; Ballerini, C.; Testa, L.; Colombo, R.M.; Spada, E.; Dani, C.; Mosca, F.;
et al. Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial. Antibiotics 2021, 10, 580.
https://doi.org/10.3390/antibiotics10050580
AMA Style
Pietrasanta C, Ronchi A, Vener C, Poggi C, Ballerini C, Testa L, Colombo RM, Spada E, Dani C, Mosca F,
et al. Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial. Antibiotics. 2021; 10(5):580.
https://doi.org/10.3390/antibiotics10050580
Chicago/Turabian Style
Pietrasanta, Carlo, Andrea Ronchi, Claudia Vener, Chiara Poggi, Claudia Ballerini, Lea Testa, Rosaria Maria Colombo, Elena Spada, Carlo Dani, Fabio Mosca,
and et al. 2021. "Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial" Antibiotics 10, no. 5: 580.
https://doi.org/10.3390/antibiotics10050580
APA Style
Pietrasanta, C., Ronchi, A., Vener, C., Poggi, C., Ballerini, C., Testa, L., Colombo, R. M., Spada, E., Dani, C., Mosca, F., & Pugni, L.
(2021). Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial. Antibiotics, 10(5), 580.
https://doi.org/10.3390/antibiotics10050580
